Uyku Bozukluklarında Psikofarmakolojik Yaklaşımlar
Özet
Uyku bozukluklarının fizyolojisini ve tedavi yaklaşımlarını inceleyen bu bilimsel metin, uyku-uyanıklık döngüsünün Asenden Retiküler Aktivatör Sistem (ARAS) ve Ventrolateral Preoptik Çekirdek (VLPO) arasındaki "flip-flop" mekanizmasıyla yönetildiğini ve uyku zamanlamasının homeostatik Süreç S ile sirkadiyen Süreç C dengesine dayandığını açıklamaktadır. Toplumda yaygın görülen uykusuzluk (insomnia) hastalığı ICSD-3 ile kronik ve kısa süreli olarak sınıflandırılmış olup tedavisinde ilk adım uyku hijyeni ve Bilişsel Davranışçı Terapi (BDT) iken, farmakoterapide benzodiazepinler, Z-ilaçları, melatonin agonistleri ve oreksin antagonistleri tercih edilmektedir. Gündüz aşırı uykululukla karakterize narkolepsi tedavisinde modafinil ve pitolizan gibi uyanıklık artırıcılar ile katapleksi için sodyum oksibat öne çıkmaktadır. Solunumun uykuda durmasıyla belirgin uyku apnesi, obstrüktif ve merkezi olarak ayrılmakta ve kilo kontrolü ile hava yolu basıncı tedavileriyle yönetilmektedir. Son olarak, gece terörü, uyurgezerlik ve kabuslar gibi parasomniler ile huzursuz bacak sendromu gibi hareket bozukluklarında ise dopamin agonistleri, klonazepam ve demir takviyeleri kullanılmaktadır.
The scientific text, which examines the physiology and treatment approaches of sleep disorders, explains that the sleep-wake cycle is governed by the "flip-flop" mechanism between the Ascending Reticular Activating System (ARAS) and the Ventrolateral Preoptic Nucleus (VLPO), and that sleep timing is based on the balance between homeostatic Process S and circadian Process C. Insomnia, which is common in society, is classified as chronic and short-term by ICSD-3; while the first step in its treatment is sleep hygiene and Cognitive Behavioral Therapy (CBT), benzodiazepines, Z-drugs, melatonin agonists, and orexin antagonists are preferred in pharmacotherapy. In the treatment of narcolepsy, characterized by excessive daytime sleepiness, wake-promoting agents such as modafinil and pitolisant, and sodium oxybate for cataplexy stand out. Sleep apnea, marked by the cessation of breathing during sleep, is divided into obstructive and central types and is managed with weight control and airway pressure treatments. Finally, for parasomnias such as night terrors, sleepwalking, and nightmares, as well as movement disorders like restless legs syndrome, dopamine agonists, clonazepam, and iron supplements are utilized.
Referanslar
Siegel, J. M. (2005). REM sleep. Principles and practice of sleep medicine, 4, 120-135.
Tononi, G., & Cirelli, C. (2006). Sleep function and synaptic homeostasis. Sleep medicine reviews, 10(1), 49-62.
Bryant, P. A., Trinder, J., & Curtis, N. (2004). Sick and tired: does sleep have a vital role in the immune system?. Nature Reviews Immunology, 4(6), 457-467.
Stickgold, R. (2005). Sleep-dependent memory consolidation. Nature, 437(7063), 1272-1278.
Altevogt, B. M., & Colten, H. R. (Eds.). (2006). Sleep disorders and sleep deprivation: an unmet public health problem.
Schulz, H. (2008). Rethinking sleep analysis: Comment on the AASM manual for the scoring of sleep and associated events. Journal of Clinical Sleep Medicine, 4(2), 99-103.
Öztürk MO, Uluşahin A. (2020) Ruh Sağlığı ve Bozuklukları. 16. Baskı, Ankara: Nobel Tıp Kitapevleri
Silber, M. H., Ancoli-Israel, S., Bonnet, M. H., Chokroverty, S., Grigg-Damberger, M. M., Hirshkowitz, M., ... & Iber, C. (2007). The visual scoring of sleep in adults. Journal of clinical sleep medicine, 3(02), 121-131.
Bianchi, M. T., & Thomas, R. J. (2013). Technical advances in the characterization of the complexity of sleep and sleep disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 45, 277-286.
Fuller, P. M., Gooley, J. J., & Saper, C. B. (2006). Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback. Journal of biological rhythms, 21(6), 482-493.
Saper, C. B., Chou, T. C., & Scammell, T. E. (2001). The sleep switch: hypothalamic control of sleep and wakefulness. Trends in neurosciences, 24(12), 726-731.
Saper, C. B., Scammell, T. E., & Lu, J. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature, 437(7063), 1257-1263.
Schwartz, J. R., & Roth, T. (2008). Neurophysiology of sleep and wakefulness: basic science and clinical implications. Current neuropharmacology, 6(4), 367-378.
Fuller, P. M., Gooley, J. J., & Saper, C. B. (2006). Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback. Journal of biological rhythms, 21(6), 482-493.
Verret, L., Goutagny, R., Fort, P., Cagnon, L., Salvert, D., Léger, L., ... & Luppi, P. H. (2003). A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC neuroscience, 4(1), 1-10.
Lee, M. G., Hassani, O. K., Alonso, A., & Jones, B. E. (2005). Cholinergic basal forebrain neurons burst with theta during waking and paradoxical sleep. Journal of Neuroscience, 25(17), 4365-4369.
Achermann, P., & Borbély, A. A. (2003). Mathematical models of sleep regulation. Frontiers in Bioscience-Landmark, 8(6), 683-693.
Borbely, A. A., & Tobler, I. (1985). Homeostatic and circadian principles in sleep regulation in the rat. Brain mechanisms of sleep, 35-44.
Benington, J. H., Kodali, S. K., & Heller, H. C. (1995). Stimulation of A1 adenosine receptors mimics the electroencephalographic effects of sleep deprivation. Brain research, 692(1-2), 79-85.
Scammell, T. E., Estabrooke, I. V., McCarthy, M. T., Chemelli, R. M., Yanagisawa, M., Miller, M. S., & Saper, C. B. (2000). Hypothalamic arousal regions are activated during modafinil-induced wakefulness. Journal of Neuroscience, 20(22), 8620-8628.
Strecker, R. E., Morairty, S., Thakkar, M. M., Porkka-Heiskanen, T., Basheer, R., Dauphin, L. J., ... & McCarley, R. W. (2000). Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behavioural brain research, 115(2), 183-204.
Moore, R. Y. (2007). Suprachiasmatic nucleus in sleep–wake regulation. Sleep medicine, 8, 27-33.
Stuck, B. A., Maurer, J. T., Schlarb, A. A., Schredl, M., & Weeß, H. G. (2021). Practice of Sleep Medicine. Springer International Publishing.Geddes, J. R., & Andreasen, N. C. (2020). New Oxford textbook of psychiatry. Oxford University Press, USA.
Geddes, J. R., & Andreasen, N. C. (2020). New Oxford textbook of psychiatry. Oxford University Press, USA.
Sadek, J. (2021). Clinician's Guide to Psychopharmacology. Springer International Publishing.
Dündar, Y., Dodd, S., Strobl, J., Boland, A., Dickson, R., & Walley, T. (2004). Comparative efficacy of newer hypnotic drugs for the short‐term management of insomnia: a systematic review and meta‐analysis. Human Psychopharmacology: Clinical and Experimental, 19(5), 305-322.
Kripke, D. F. (2016). Mortality risk of hypnotics: strengths and limits of evidence. Drug Safety, 39(2), 93-107.
Kryger, M. H., Roth, T., & Dement, W. C. (2010). Principles and Practice of Sleep Medicine E-Book. Elsevier Health Sciences.
Goswami, M., Pandi-Perumal, S. R., & Thorpy, M. J. (2010). Narcolepsy. New York, NY: Springer.
McDaid, C., Griffin, S., Weatherly, H., Duree, K., Van der Burgt, M., Van Hout, S., ... & Westwood, M. (2009). Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health technology assessment (Winchester, England), 13(4), iii-iv.
Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013). Increased prevalence of sleep-disordered breathing in adults. American journal of epidemiology, 177(9), 1006-1014.
Benca, R. M., Obermeyer, W. H., Thisted, R. A., & Gillin, J. C. (1992). Sleep and psychiatric disorders: a meta-analysis. Archives of general psychiatry, 49(8), 651-668.
